SEC
LEGN icon

Seven Eight Capital’s Legend Biotech LEGN Stock Holding History

Seven Eight Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,113
Closed -$215K – 664
2023
Q2 		$215K Sell
3,113
-1,350
-30% -$88.2K 0.04% 449
2023
Q1 		$215K Buy
+4,463
New +$218K 0.04% 389

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Seven Eight Capital's LEGN Position: Q3 2023 in Review

Seven Eight Capital sold out of Legend Biotech (LEGN) in Q3 2023, closing a stake of 3,113 shares — an estimated $215K sold.

Seven Eight Capital first reported a position in LEGN in Q1 2023 and held it in 2 quarters. The position peaked at $215K in Q1 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2023.

  • Seven Eight Capital reported no remaining Legend Biotech position as of Q3 2023 after selling out during the quarter.
  • Seven Eight Capital sold 3,113 Legend Biotech shares in Q3 2023, an estimated $215K.
  • Seven Eight Capital first reported a position in Legend Biotech in Q1 2023 and held it in 2 quarters.
  • Seven Eight Capital's Legend Biotech position peaked at $215K in Q1 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2023.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.